8-K
Current Report
Ovid Therapeutics Inc. Filed Acc 0001564590-21-010415
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading ovid-8k_20210303.htm…